From November 11, 2022 to November 30, 2022, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CAD 0 million under the buyback announced on November 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 CAD | -2.63% | +1.37% | -10.84% |
1st Jan change | Capi. | |
---|---|---|
-10.84% | 50.22M | |
-.--% | 339M | |
+20.99% | 231M | |
+3.09% | 213M | |
+32.56% | 171M | |
+125.65% | 136M | |
-28.57% | 121M | |
+27.93% | 115M | |
-51.45% | 102M | |
-7.69% | 87.33M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.